Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07658703

Physiotherapeutic Approach to Superficial and Deep Dyspareunia in Women With Chronic Pelvic Pain: Comparison Between In-person and Telehealth Care.

Adequate sexual function is considered an important factor in satisfaction and overall quality of life for both men and women. It is estimated 16% to 40% of women suffer from some form of sexual dysfunction, which is currently considered a public health problem and its investigation is recommended because it causes significant changes in the quality of life of these women. Among the painful disorders, genitopelvic pain, which includes dyspareunia, vaginismus and vulvodynia, dyspareunia stands out, which involves the appearance of pain during or after sexual intercourse, directly affecting physical health, as well as sexual and mental well-being. Among the treatment techniques for dyspareunia in women with chronic pelvic pain, there is the Thiele massage, which provides an inhibitory effect on muscle tension caused by spasms, relaxing, stretching and relieving coital pain. In this sense, we know that physiotherapy treatment has an important role in improving pain symptoms, since musculoskeletal dysfunction may be present in women with dyspareunia, which makes it relevant to verify whether the approach via telecare would have the same effectiveness as the in-person technique that has scientific proof, since through telecare the woman would not be exposed to the risks that are inherent to going to an outpatient clinic, it could cover more women and this would also bring a greater cost-benefit to the unified health system.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Ribeirão Preto Clinical Hospital

Ribeirão Preto, São Paulo, 14048-900, Brazil

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Women diagnosed with CPP and deep or shallow penetration dyspareunia;
  • Over 18 years of age;
  • Willingness to voluntarily participate in the study, accepting randomization to either of the two treatment arms;
  • Signature of the Free and Informed Consent Form (FICF).

Exclusion criteria

  • Women with penetrative dyspareunia without pelvic floor muscle spasm;
  • Women without an active sex life

Treatment and study plan

Face-to-face treatment

Procedure

Massage in the direction of the muscle fibers with a pressure tolerable for the patient for 5 minutes. The treatment will be carried out in the outpatient clinic by a previously trained physiotherapist.

Telecare

Procedure

Massage in the direction of the muscle fibers with a pressure tolerable for the patient for 5 minutes. The treatment will be carried out by the patient at home and guided by a previously trained physiotherapist via teleconsultation.

Primary outcomes

  1. Visual Analog Scale (EAV)

    Time frame: From acceptance to participate in the study until the end in 10 weeks in the reassessment.

    The visual analog scale (VAS) for pain is the most widely used unidimensional scale in clinical practice due to its feasibility, speed, and clinical application. It measures pain from 0 to 10, with higher scores indicating greater pain.

Sponsors and collaborators

Lead sponsor

University of Sao Paulo

Other

Collaborators

  • University of Sao Paulo General Hospital

Registry information

Important dates

Study start
2025
Primary completion
2026
Study completion
2028
First posted
Jun 22, 2026
Registry last updated
Jun 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.